Sign In
Buy KRTX
$329.83
+0 (+0%)
At Close: Jun 14, 2024
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
Parametric Portfolio Associates LLC Sells 2,877 Shares of Karuna Therapeutics (NASDAQ:KRTX)
04:30am, Sunday, 05'th Jul 2020
Parametric Portfolio Associates LLC lowered its position in shares of Karuna Therapeutics (NASDAQ:KRTX) by 19.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities &
2020 Insights into the Global Schizophrenia Market and Competitive Landscape - ResearchAndMarkets.com
12:00am, Thursday, 02'nd Jul 2020
The
Critical Contrast: Karuna Therapeutics (KRTX) & Its Peers
02:40am, Tuesday, 30'th Jun 2020
Karuna Therapeutics (NASDAQ: KRTX) is one of 618 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare Karu
Hedge Funds Keep Buying Karuna Therapeutics, Inc. (KRTX)
11:14pm, Sunday, 28'th Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
FY2024 EPS Estimates for Karuna Therapeutics (NASDAQ:KRTX) Increased by Oppenheimer
02:08am, Sunday, 28'th Jun 2020
Karuna Therapeutics (NASDAQ:KRTX) – Equities researchers at Oppenheimer lifted their FY2024 EPS estimates for Karuna Therapeutics in a report released on Wednesday, June 24th. Oppenheimer analyst J.
Karuna Program Progress, And Other News: The Good, Bad And Ugly Of Biopharma
01:42am, Friday, 26'th Jun 2020
Karuna's clinical program for acute psychosis is about to proceed. Corbus reports progress for its phase 2 program. Myovant reports positive data for relugolix.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Insiders Increased Their Holdings
12:56pm, Wednesday, 24'th Jun 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
Analysts Offer Insights on Healthcare Companies: Karuna Therapeutics (NASDAQ: KRTX) and aTyr Pharma (NASDAQ: LIFE) - Markets
10:21am, Wednesday, 24'th Jun 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Karuna Therapeutics (KRTX – Research
Karuna Therapeutics (KRTX) vs. Its Peers Head to Head Survey
01:36am, Wednesday, 24'th Jun 2020
Karuna Therapeutics (NASDAQ: KRTX) is one of 618 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Karuna Therape
Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabl
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Troy A. Ignelzi Sells 6,000 Shares of Karuna Therapeutics (NASDAQ:KRTX) Stock
07:36am, Friday, 19'th Jun 2020
Karuna Therapeutics (NASDAQ:KRTX) CFO Troy A. Ignelzi sold 6,000 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $89.75, for a to
Bank of New York Mellon Corp Boosts Position in Karuna Therapeutics (NASDAQ:KRTX)
04:22am, Wednesday, 10'th Jun 2020
Bank of New York Mellon Corp increased its holdings in Karuna Therapeutics (NASDAQ:KRTX) by 39.0% in the first quarter, HoldingsChannel.com reports. The fund owned 55,308 shares of the company’s sto
Karuna Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
10:30am, Wednesday, 03'rd Jun 2020
Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabl
